Perceptions and expectations of adults with type 1 diabetes for the use of artificial pancreas systems with and without glucagon addition: Results of an online survey
The first hybrid artificial pancreas (AP) systems with insulin only (mono-hormonal) have recently reached the market while next generations systems are under development including those with glucagon addition (bi-hormonal). Understanding the expectations and impressions of future potential users about AP systems is important for optimal use of this clinically effective emerging technology.
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - Category: Nutrition Authors: Nadine Taleb, Ariane Quintal, Rohan Rakheja, Virginie Messier, Laurent Legault, Eric Racine, R émi Rabasa-Lhoret Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 1 | Endocrinology | Heart | Hormones | Insulin | Nutrition | Pancreas